← back to search

Natalia Bogdanova

N.N. Alexandrov National Cancer Centre ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, DNA Repair Mechanisms, and Genetic factors in colorectal cancer.
h-index
68
citations
24,465
works
310
NIH funding
primary concept
email

Recent publications

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Nature Communications 2025cited by 7position: middledoi
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
The Breast 2025cited by 1position: middledoi
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Nature Genetics 2024cited by 44position: middledoi
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions
The American Journal of Human Genetics 2024cited by 25position: middledoi
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
Breast Cancer Research 2024cited by 11position: middledoi
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction
medRxiv 2024cited by 10position: middledoi
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset
The American Journal of Human Genetics 2024cited by 8position: middledoi
Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Nature Genetics 2024cited by 3position: middledoi
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
medRxiv 2024cited by 3position: middledoi
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
medRxiv 2024cited by 3position: middledoi
Analysis of variants in untranslated and promoter regions and breast cancer risk using whole genome sequencing data
medRxiv 2024cited by 1position: middledoi
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Genome Medicine 2023cited by 15position: middledoi
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
European Journal of Human Genetics 2023cited by 13position: middledoi
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Journal of Medical Genetics 2023cited by 5position: middledoi
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
medRxiv 2023cited by 5position: middledoi
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers 2023cited by 1position: middledoi
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
JAMA Oncology 2022cited by 184position: middledoi
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
British Journal of Sports Medicine 2022cited by 96position: middledoi
Polygenic risk modeling for prediction of epithelial ovarian cancer risk
European Journal of Human Genetics 2022cited by 68position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
Genome Medicine 2022cited by 54position: middledoi
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
European Journal of Nuclear Medicine and Molecular Imaging 2022cited by 28position: middledoi
Rare germline copy number variants (CNVs) and breast cancer risk
Communications Biology 2022cited by 14position: middledoi
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci
JNCI Journal of the National Cancer Institute 2022cited by 13position: middledoi
Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk
European Journal of Human Genetics 2022cited by 4position: middledoi
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
British Journal of Cancer 2021cited by 22position: middledoi
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
The American Journal of Human Genetics 2021cited by 12position: middledoi
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Cancers 2021cited by 9position: middledoi
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
British Journal of Cancer 2021cited by 9position: middledoi
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
medRxiv 2021cited by 5position: middledoi
Rare copy number variants (CNVs) and breast cancer risk
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thilo Dörk · Lund University8 papers (2012–2019)Hans Christiansen · Medizinische Hochschule Hannover4 papers (2012–2022)Tjoung-Won Park-Simon · University Hospital Münster4 papers (2012–2016)Peter Hillemanns · Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe3 papers (2012–2016)Peter Schürmann · London School of Hygiene & Tropical Medicine3 papers (2012–2016)Jan Lubiński · Radboud University Medical Center2 papers (2014–2019) · 2 papers (2014–2019)Anna Jakubowska · International Hereditary Cancer Center2 papers (2014–2019)Cezary Cybulski · Mississippi State University2 papers (2014–2019)Thomas Brüning · Institute for Prevention and Occupational Medicine1 papers (2013–2013)Fergus J. Couch · Mayo Clinic1 papers (2013–2013)Peter A. Fasching · National Cancer Centre Japan1 papers (2013–2013)Jingmei Li · Agency for Science, Technology and Research1 papers (2013–2013)Elke Krischke · Medizinische Hochschule Hannover1 papers (2022–2022) · 1 papers (2019–2019)Magdalena Ratajska · University of Otago1 papers (2019–2019)Beate Pesch · Institute for Prevention and Occupational Medicine1 papers (2013–2013)Kerstin Borgmann · Center for Cancer Research1 papers (2012–2012) · 1 papers (2014–2014)Tomasz Huzarski · International Hereditary Cancer Center1 papers (2019–2019)